Literature DB >> 1435898

Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.

M Theobald1, T Nierle, D Bunjes, R Arnold, H Heimpel.   

Abstract

BACKGROUND: Acute graft-versus-host disease (GVHD) is a serious complication of allogeneic bone marrow transplantation from an HLA-identical sibling. There is no practical test before transplantation that gives sufficient information to predict the degree of allogeneic reactivity between HLA-identical siblings.
METHODS: We determined the frequency with which host-specific interleukin-2-secreting donor T-cell precursors occurred in 16 consecutive pairs of HLA-identical siblings before they underwent marrow grafting. The results were correlated with the development of acute GVHD after transplantation.
RESULTS: High frequencies of host-specific T-cell precursors (> or = 1 per 100,000) were detectable before transplantation in eight donors whose siblings later had severe (grade II or III) acute GVHD. Among the donors to eight patients with mild (grade 0 or 1) acute GVHD, low frequencies (< 1 per 100,000) were found.
CONCLUSIONS: Analysis of the frequency of such cells before transplantation may be a useful predictor of severe acute GVHD in allogeneic bone marrow transplantation between HLA-identical siblings. It is possible that the patients at risk for serious acute GVHD after marrow grafting may benefit from some alternative form of immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1435898     DOI: 10.1056/NEJM199212033272301

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  13 in total

1.  T helper frequencies in peripheral blood reflect donor-directed reactivity in the graft after clinical heart transplantation.

Authors:  L M Vaessen; C R Daane; A P Maat; A H Balk; F H Claas; W Weimar
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease.

Authors:  Anandharaman Veerapathran; Joseph Pidala; Francisca Beato; Brian Betts; Jongphil Kim; Joel G Turner; Marc K Hellerstein; Xue-Zhong Yu; William Janssen; Claudio Anasetti
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

3.  A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation.

Authors:  L Sviland; A M Dickinson
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

4.  Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation.

Authors:  Joseph McGuirk; Gang Hao; Weijian Hou; Sunil Abhyankar; Casey Williams; Weisi Yan; Jianda Yuan; Xiuqin Guan; Robert Belt; Shaun Dejarnette; Jeffery Wieman; Ying Yan
Journal:  J Hematol Oncol       Date:  2009-04-20       Impact factor: 17.388

5.  CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.

Authors:  B R Blazar; P A Taylor; R J Noelle; D A Vallera
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

Review 6.  Clinical application of allogeneic peripheral blood stem cells transplantation.

Authors:  J Tanaka; M Kasai; M Imamura; M Asaka
Journal:  Ann Hematol       Date:  1995-12       Impact factor: 3.673

7.  Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.

Authors:  K R Cooke; G R Hill; J M Crawford; D Bungard; Y S Brinson; J Delmonte; J L Ferrara
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

Review 8.  Graft-versus-host disease and the Th1/Th2 paradigm.

Authors:  W Krenger; J L Ferrara
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

9.  Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.

Authors:  L M Faber; J van der Hoeven; E Goulmy; A L Hooftman-den Otter; S A van Luxemburg-Heijs; R Willemze; J H Falkenburg
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  Association of serum interleukin-7 levels with the development of acute graft-versus-host disease.

Authors:  Robert M Dean; Terry Fry; Crystal Mackall; Seth M Steinberg; Fran Hakim; Daniel Fowler; Jeanne Odom; Jason Foley; Ronald Gress; Michael R Bishop
Journal:  J Clin Oncol       Date:  2008-11-10       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.